| 1 |
coronavirus disease 2019
(42978 times)
|
Medicine
(4742 times)
|
SARS-CoV-2 (10667 times)
CI (1770 times)
ICU (1368 times)
|
2019 The first community outbreak of COVID-19 in Viet Nam: description and lessons learned.
|
| 2 |
coronavirus-induced disease 2019
(29 times)
|
Communicable Diseases
(4 times)
|
SARS-CoV-2 (16 times)
ACE2 (5 times)
CT (3 times)
|
2020 Assessment of Real-Time RT-PCR Kits for SARS-CoV-2 Detection.
|
| 3 |
CoV disease 2019
(21 times)
|
Microbiology
(4 times)
|
SARS-CoV-2 (11 times)
CoV (6 times)
ACE2 (4 times)
|
2020 Zoonotic origins of human coronaviruses.
|
| 4 |
coronavirus pandemic of 2019
(20 times)
|
Public Health
(2 times)
|
SARS-CoV-2 (2 times)
AF (1 time)
AIS (1 time)
|
2020 Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CLpro of 2019-nCoV than monomeric anthocyanins: A structural-relationship activity study with 10 anthocyanins using in-silico approaches.
|
| 5 |
SARS-CoV-2 disease 2019
(10 times)
|
Pulmonary Medicine
(2 times)
|
COPD (1 time)
CRS (1 time)
cTnI (1 time)
|
2020 COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
|
| 6 |
coronavirus identified in 2019
(9 times)
|
Pharmacy
(7 times)
|
VGSC (1 time)
|
2020 Letter to the Editor "COVID-19 and Neurosurgical Education in Africa: Making Lemonade from Lemons".
|
| 7 |
2019-coronavirus disease
(8 times)
|
Diabetes Mellitus
(1 time)
|
SARS-CoV-2 (2 times)
Anti-IL6 (1 time)
CHM (1 time)
|
2020 Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression.
|
| 8 |
coronavirus 2019 pandemic
(8 times)
|
Medicine
(3 times)
|
ACE-2 (1 time)
CABG (1 time)
CSSE (1 time)
|
2020 Screening of COVID-19 in children admitted to the hospital for acute problems: preliminary data.
|
| 9 |
coronavirus associated disease 2019
(6 times)
|
Medicine
(2 times)
|
ACS (1 time)
CI (1 time)
ED (1 time)
|
2020 Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic.
|
| 10 |
clinical outcomes, named coronavirus disease-2019
(4 times)
|
Medical Informatics
(1 time)
|
SARS-CoV-2 (2 times)
ACEIs (1 time)
ARBs (1 time)
|
2021 Relationships between Viral Load and the Clinical Course of COVID-19.
|
| 11 |
context of 2019 coronavirus disease
(4 times)
|
Translational Medical Research
(1 time)
|
NSFD (1 time)
ODEs (1 time)
SARS-CoV-2 (1 time)
|
2020 Clinical and imaging features of COVID-19.
|
| 12 |
cause of coronavirus 2019 disease
(3 times)
|
Nuclear Medicine
(1 time)
|
SARS (1 time)
SARS-CoV-2 (1 time)
|
2020 Olfactory Dysfunction in the COVID-19 Outbreak.
|
| 13 |
COVID group
(3 times)
|
Orthopedics
(1 time)
|
BF (1 time)
Gas-M (1 time)
Glut-M (1 time)
|
2020 Vascular Surgery During COVID-19 Emergency in Hub Hospitals of Lombardy: Experience on 305 Patients.
|
| 14 |
current outbreak of coronavirus disease-2019
(3 times)
|
Virology
(1 time)
|
SARS-CoV-2 (1 time)
|
2020 Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.
|
| 15 |
Abstract-Coronavirus disease 2019
(2 times)
|
Biopharmaceutics
(1 time)
|
BSL-3 (1 time)
ICEs (1 time)
|
2020 Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens.
|
| 16 |
CoronaVirus Disease appeared in 2019
(2 times)
|
Psychiatry
(1 time)
|
CoHL (1 time)
HL (1 time)
LOC (1 time)
|
2021 Self-isolation, psychotic symptoms and cognitive problems during the COVID-19 worldwide outbreak.
|
| 17 |
coronavirus emerged in December of 2019
(2 times)
|
Statistics as Topic
(1 time)
|
---
|
2020 Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.
|
| 18 |
current ongoing coronavirus disease 19
(2 times)
|
Biomedical Engineering
(1 time)
|
ACE2 (1 time)
RBD (1 time)
|
2020 Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.
|
| 19 |
2019-coronavirus infected disease
(1 time)
|
Microbiology
(1 time)
|
Ly (1 time)
WBC (1 time)
|
2020 A case series describing the epidemiology and clinical characteristics of COVID-19 infection in Jilin Province.
|
| 20 |
beta-coronavirus discovered in Wuhan in 2019
(1 time)
|
|
---
|
2022 A case report, bilateral spontaneous pneumothorax as a late complication for SARS CoV-2 infection.
|
| 21 |
cancer overcomes Coronavirus disease 2019
(1 time)
|
Urologic Diseases
(1 time)
|
BCG (1 time)
CT (1 time)
TURB (1 time)
|
2021 COVID-19 impact on bladder cancer-orientations for diagnosing, decision making, and treatment.
|
| 22 |
case report, we present acoronavirus disease 2019
(1 time)
|
|
---
|
2021 A Unique Case of Acute Coronary Syndrome in a Patient With COVID-19 Infection.
|
| 23 |
cases have been reported aftercoronavirus disease 2019
(1 time)
|
|
AOSD (1 time)
|
2022 Adult-Onset Still's Disease After the ChAdOx1 nCoV-19 Vaccine.
|
| 24 |
causative etiology of 'Corona Virus Disease-2019
(1 time)
|
|
SARS-CoV-2 (1 time)
WHO (1 time)
|
2021 Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives.
|
| 25 |
causative virus of Coronavirus disease-2019
(1 time)
|
Genital Diseases, Female
(1 time)
|
ACE-2 (1 time)
PCOS (1 time)
|
2021 Are women with polycystic ovary syndrome more vulnerable to COVID-19 infection?
|
| 26 |
cause of the 2019-nCOV disease
(1 time)
|
Biochemistry
(1 time)
|
ARDS (1 time)
IVIG (1 time)
SARS-CoV-2 (1 time)
|
2021 Recent advances in antibody-based immunotherapy strategies for COVID-19.
|
| 27 |
caused by the virus 'coronavirus disease 2019
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2021 COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future.
|
| 28 |
caused by this agent aquired the name coronavirus disease 2019
(1 time)
|
History of Medicine
(1 time)
|
RT-PCR (1 time)
SARS-CoV-2 (1 time)
WHO (1 time)
|
2020 Diagnostic consideration and bedside estimation of the prognosis in COVID-19 patients
|
| 29 |
causes the novel betacoronavirus 2019 disease
(1 time)
|
Transplantation
(1 time)
|
CMV (1 time)
SARS-CoV-2 (1 time)
SOT (1 time)
|
2021 Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategies.
|
| 30 |
centers were obtained detailing precoronavirus disease 2019
(1 time)
|
Medicine
(1 time)
|
NSTEMI (1 time)
PCI (1 time)
PM (1 time)
|
2020 Impact of temporary traffic bans on the risk of acute coronary syndromes in a large metropolitan area.
|
| 31 |
challenge of facing coronavirus disease-19
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2021 Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates.
|
| 32 |
chest manifestations ofcoronavirus disease 2019
(1 time)
|
|
CT-SS (1 time)
GGOs (1 time)
HRCT (1 time)
|
2020 An Analysis of High-Resolution Computed Tomography Chest Manifestations of COVID-19 Patients in Pakistan.
|
| 33 |
children and their parent during 2019 novelcoronavirus disease
(1 time)
|
Psychology
(1 time)
|
PTSD (1 time)
|
2020 Anxiety, depression and PTSD among children and their parent during 2019 novelcoronavirus disease (COVID-19) outbreak in China.
|
| 34 |
children;Coronavirus Disease 2019
(1 time)
|
Medicine
(1 time)
|
---
|
2021 Clinical Profile of COVID-19 in Children and Research Progress on Angiotensin-converting Enzyme 2: A Mini-review.
|
| 35 |
clinical phenotypes and outcomes ofcoronavirus disease 2019
(1 time)
|
Virology
(1 time)
|
PICU (1 time)
SARS-CoV-2 (1 time)
|
2022 Influenza is more severe than our newest enemy (COVID-19) in hospitalized children: Experience from a tertiary center.
|
| 36 |
clinical pictures with acoronavirus disease 2019
(1 time)
|
|
---
|
2021 [Pneumonia in old age].
|
| 37 |
clinical validation, coronavirus disease 2019
(1 time)
|
Hematology
(1 time)
|
CCP (1 time)
CI (1 time)
ICU (1 time)
|
2020 Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients.
|
| 38 |
Cochrane Say aboutCoronavirus Disease 2019
(1 time)
|
|
---
|
2020 What Does Cochrane Say about…Coronavirus Disease 2019 (COVID-19)?
|
| 39 |
cohorts of hospitalised coronavirus disease-2019
(1 time)
|
Biology
(1 time)
|
AUC (1 time)
DM (1 time)
SHAP (1 time)
|
2022 COVID-19 mortality risk assessments for individuals with and without diabetes mellitus: Machine learning models integrated with interpretation framework.
|
| 40 |
combination of severity indicators
(1 time)
|
Virology
(1 time)
|
ICU (1 time)
|
2022 Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022.
|
| 41 |
comment on pre-coronavirus disease 2019
(1 time)
|
Aerospace Medicine
(1 time)
|
---
|
2020 Mental Health Care for Rural and Remote Australians During the Coronavirus Disease 2019 Pandemic.
|
| 42 |
compared antibiotic prescribing before and during the -coronavirus disease 2019
(1 time)
|
Communicable Diseases
(1 time)
|
---
|
2022 Sustained Reduction in Urgent Care Antibiotic Prescribing During the Coronavirus Disease 2019 Pandemic: An Academic Medical Center's Experience.
|
| 43 |
compared with other health events
(1 time)
|
|
HRs (1 time)
|
2020 Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA.
|
| 44 |
complications of coronavirus infectious disease-19
(1 time)
|
Virology
(1 time)
|
AF (1 time)
CI (1 time)
OR (1 time)
|
2022 Association of atrial fibrillation with infectivity and severe complications of COVID-19: A nationwide cohort study.
|
| 45 |
complications of the COronaVIrus Disease-2019
(1 time)
|
Hematology
(1 time)
|
---
|
2021 Is SARS-CoV-2 infection an emerging risk factor for splanchnic venous thrombosis?
|
| 46 |
components of mRNA vaccines against coronavirus disease 2019
(1 time)
|
Internal Medicine
(1 time)
|
SARS-CoV-2 (1 time)
|
2021 [Allergic reactions to COVID-19 vaccines: evidence and practice-oriented approach].
|
| 47 |
confirmed or suspected coronavirus disease-2019
(1 time)
|
Critical Care
(1 time)
|
---
|
2020 Cause of Death Certification in COVID-19 Deaths.
|
| 48 |
contagious and deadlycoronavirus disease 2019
(1 time)
|
Geriatrics
(1 time)
|
---
|
2020 Elderly care in the time of coronavirus: Perceptions and experiences of care home staff in Pakistan.
|
| 49 |
continuing outbreak of thecoronavirus disease 2019
(1 time)
|
Epidemiology
(1 time)
|
---
|
2020 Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic.
|
| 50 |
Corona Virus Disease reported in 2019
(1 time)
|
Biochemistry
(1 time)
|
RT-qPCR (1 time)
SARS-CoV-2 (1 time)
|
2021 Dual-target one-step nested PCR for sensitive detection of SARS-CoV-2 nucleic acids.
|
| 51 |
Corona virus disease that was first recorded in 2019
(1 time)
|
Virus Diseases
(1 time)
|
---
|
2021 A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery.
|
| 52 |
Corona-2019 virus disease
(1 time)
|
Geriatrics
(1 time)
|
CT (1 time)
CXR (1 time)
|
2022 COVID-19 detection in CT and CXR images using deep learning models.
|
| 53 |
coronavirus 2019 disease infection
(1 time)
|
Cardiovascular Diseases
(1 time)
|
---
|
2020 Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.
|
| 54 |
coronavirus breaking out in the end of 2019
(1 time)
|
Environmental Health
(1 time)
|
ALWC (1 time)
Gly (1 time)
mGly (1 time)
|
2020 Enhanced photochemical formation of secondary organic aerosols during the COVID-19 lockdown in Northern China.
|
| 55 |
Coronavirus Disease - 2019-nCoV
(1 time)
|
Nursing
(1 time)
|
LRTIs (1 time)
WHO (1 time)
|
2020 Coronavirus Disease - 2019-nCoV (COVID-19).
|
| 56 |
coronavirus disease 2019 </mac_aq>
(1 time)
|
Medicine
(1 time)
|
---
|
2020 Expert recommendations for the care of newborns of mothers with COVID-19.
|
| 57 |
Coronavirus disease 2019 pneumonia broke out in 2019
(1 time)
|
Complementary Therapies
(1 time)
|
ACE2 (1 time)
GO (1 time)
KEGG (1 time)
|
2020 Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
|
| 58 |
coronavirus disease 2019, also called
(1 time)
|
Obstetrics
(1 time)
|
SARS-CoV-2 (1 time)
WHO (1 time)
|
2022 Atypical Eclampsia in a Pregnant Woman Infected by COVID-19.
|
| 59 |
coronavirus disease emerged in December 2019
(1 time)
|
Molecular Biology
(1 time)
|
SARS-CoV-2 (1 time)
|
2021 Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
|
| 60 |
Coronavirus disease of the pandemic in 2019
(1 time)
|
Environmental Health
(1 time)
|
CMW (1 time)
LCA (1 time)
MW (1 time)
|
2022 Principal of environmental life cycle assessment for medical waste during COVID-19 outbreak to support sustainable development goals.
|
| 61 |
Coronavirus Disease reported at the end of 2019
(1 time)
|
|
PEVs (1 time)
SDM (1 time)
|
2022 The Chinese plug-in electric vehicles industry in post-COVID-19 era towards 2035: Where is the path to revival?
|
| 62 |
coronavirus disease that arises in the end of 2019
(1 time)
|
Biochemistry
(1 time)
|
MDS (1 time)
|
2021 Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach.
|
| 63 |
coronavirus disease that presumably began in 2019
(1 time)
|
Molecular Biology
(1 time)
|
NF-kappaB (1 time)
SARS-CoV-2 (1 time)
|
2021 The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease.
|
| 64 |
Coronavirus disease, first detected in late 2019
(1 time)
|
Cardiovascular Diseases
(1 time)
|
---
|
2021 Application of Machine Learning in Diagnosis of COVID-19 Through X-Ray and CT Images: A Scoping Review.
|
| 65 |
Coronavirus disease-2019 infection
(1 time)
|
Urologic Diseases
(1 time)
|
PMD (1 time)
|
2021 Penile Mondor's in a Covid-19 patient on prophylactic anti-thrombosis with rivaroxaban: a case report.
|
| 66 |
Coronavirus disease-2019 outbreak
(1 time)
|
Vascular Diseases
(1 time)
|
DUS (1 time)
DVT (1 time)
ICU (1 time)
|
2020 How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units.
|
| 67 |
coronavirus first reported in Wuhan City in China in 2019
(1 time)
|
|
---
|
2021 Change in mental health, physical health, and social relationships during highly restrictive lockdown in the COVID-19 pandemic: evidence from Australia.
|
| 68 |
coronavirus infection 2019 disease
(1 time)
|
|
ROC (1 time)
RV (1 time)
RVFAC (1 time)
|
2022 Feasibility, Prediction and Association of Right Ventricular Free Wall Longitudinal Strain with 30-Day Mortality in Severe COVID-19 Pneumonia: A Prospective Study.
|
| 69 |
COronavirus Infectious Disease which started in 2019
(1 time)
|
Cardiology
(1 time)
|
---
|
2020 COVID-19, thromboembolic risk, and Virchow's triad: Lesson from the past.
|
| 70 |
Coronavirus outbreak in December 2019
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2020 Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
|
| 71 |
Coronavirus pandemic began in China in 2019
(1 time)
|
Neurology
(1 time)
|
ISI (1 time)
|
2021 Impact of COVID-19 pandemic on the sleep quality of medical professionals in Brazil.
|
| 72 |
coronavirus pandemic in December 2019
(1 time)
|
|
CI (1 time)
CrI (1 time)
|
2021 On the reliability of predictions on Covid-19 dynamics: A systematic and critical review of modelling techniques.
|
| 73 |
coronavirus pandemic that emerged in late 2019
(1 time)
|
Behavior
(1 time)
|
ABCD (1 time)
NCANDA (1 time)
|
2021 Retaining Adolescent and Young Adult Participants in Research During a Pandemic: Best Practices From Two Large-Scale Developmental Neuroimaging Studies (NCANDA and ABCD).
|
| 74 |
coronavirus respiratory disease 2019
(1 time)
|
Nervous System Diseases
(1 time)
|
TN (1 time)
|
2021 Teleneurology Expansion in Response to the COVID-19 Outbreak at a Tertiary Health System in New York City.
|
| 75 |
coronavirus was identified in December 2019
(1 time)
|
Medicine
(1 time)
|
ARDS (1 time)
ICU (1 time)
|
2020 Why tocilizumab could be an effective treatment for severe COVID-19?
|
| 76 |
coronavirus-associated disease that emerged in December 2019
(1 time)
|
Biochemistry
(1 time)
|
SARS-CoV (1 time)
|
2020 Stability of RNA sequences derived from the coronavirus genome in human cells.
|
| 77 |
corticosteroids on coronavirus disease 2019
(1 time)
|
Virology
(1 time)
|
---
|
2021 Efficacy of corticosteroid in patients with COVID-19: A multi-center retrospective study and meta-analysis.
|
| 78 |
count abnormalities.Coronavirus disease 2019
(1 time)
|
|
ITP (1 time)
|
2021 Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids.
|
| 79 |
CoV-asthma, CoV-COPD, respectively
(1 time)
|
Communicable Diseases
(1 time)
|
COPD (1 time)
CoV-com (1 time)
|
2021 Focusing on Asthma and Chronic Obstructive Pulmonary Disease with COVID-19.
|
| 80 |
covered the Coronavirus Disease 2019
(1 time)
|
Environmental Health
(1 time)
|
NCP (1 time)
PSCF (1 time)
SOA (1 time)
|
2021 Evolution of organic carbon during COVID-19 lockdown period: Possible contribution of nocturnal chemistry.
|
| 81 |
CovGenX rapid test
(1 time)
|
Transplantation
(1 time)
|
TSCT (1 time)
|
2022 Should Thorax Thin-Section Computed Tomography Be a Standard Diagnostic Procedure in the Evaluation of Potential Kidney Transplant Recipients? Lessons Learned From the COVID-19 Pandemic.
|
| 82 |
covid disease 19
(1 time)
|
Medicine
(1 time)
|
---
|
2020 [Coronavirus, emerging viruses].
|
| 83 |
Covid infection 2019
(1 time)
|
|
---
|
2021 Logistics and supply chain management of food industry during COVID-19: disruptions and a recovery plan.
|
| 84 |
COVID institution
(1 time)
|
Neurology
(1 time)
|
SAVE-9 (1 time)
|
2021 Validation of the Japanese version of Stress and Anxiety to Viral Epidemics-9 (SAVE-9) and relationship among stress, insomnia, anxiety, and depression in healthcare workers exposed to coronavirus disease 2019.
|
| 85 |
Covid sickness 2019
(1 time)
|
|
CNN (1 time)
|
2021 Convolutional neural network use chest radiography images for identification of COVID-19.
|
| 86 |
COVID Toes
(1 time)
|
Dermatology
(1 time)
|
CLL (1 time)
SARS-CoV-2 (1 time)
|
2021 Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.
|
| 87 |
COVID-like ILIs
(1 time)
|
Neoplasms
(1 time)
|
CI (1 time)
ICIs (1 time)
ILI (1 time)
|
2020 Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
|
| 88 |
COVID-positive
(1 time)
|
Internal Medicine
(1 time)
|
---
|
2022 Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study.
|
| 89 |
COVID-SPRING study
(1 time)
|
Virology
(1 time)
|
CI (1 time)
ONPS (1 time)
|
2021 Natural spring water gargle and direct RT-PCR for the diagnosis of COVID-19 (COVID-SPRING study).
|
| 90 |
COVIDECA Study
(1 time)
|
Cardiology
(1 time)
|
ACEI (1 time)
ARB (1 time)
|
2021 Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study).
|
| 91 |
COVIDstable patients
(1 time)
|
Critical Care
(1 time)
|
CAPICU patients (1 time)
PKM2 (1 time)
|
2020 Characterization of the Inflammatory Response to Severe COVID-19 Illness.
|
| 92 |
COVISHIELD coronavirus disease 2019
(1 time)
|
Kidney Diseases
(1 time)
|
---
|
2022 Adult-onset nephrotic syndrome following coronavirus disease vaccination.
|
| 93 |
COVISHIELDTM
(1 time)
|
Medicine
(1 time)
|
---
|
2022 Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol.
|
| 94 |
CoVS and non-CoVS, respectively
(1 time)
|
Nervous System Diseases
(1 time)
|
CSSG (1 time)
mRS (1 time)
SARS-CoV-2 (1 time)
|
2022 Clinical Features and Outcome of Stroke with COVID-19. COVID-19 Stroke Study Group (CSSG), India.
|
| 95 |
critical illness due to severecoronavirus disease 2019
(1 time)
|
|
G6PD (1 time)
SARS-CoV-2 (1 time)
|
2021 Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.
|
| 96 |
cross-contamination by microbes such as thecoronavirus disease 2019
(1 time)
|
Chemistry
(1 time)
|
---
|
2020 Food preservation techniques and nanotechnology for increased shelf life of fruits, vegetables, beverages and spices: a review.
|
| 97 |
pandemic-coronavirus disease19
(1 time)
|
|
HPV (1 time)
|
2022 [Vaccinations for pregnant women and women attempting to become pregnant].
|
| 98 |
SARS-coronavirus 2 disease initially reported in December 2019 in China
(1 time)
|
Medicine
(1 time)
|
---
|
2020 [COVID-19 : Intensive care management].
|
| 99 |
SARS-CoV-2 or the resulting corona disease 2019
(1 time)
|
Statistics as Topic
(1 time)
|
SARS-CoV-2 (1 time)
|
2021 Design aspects of COVID-19 treatment trials: Improving probability and time of favorable events.
|
| 100 |
SARS-CoV-2, responsible for coronavirus disease-2019
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2021 Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
|
A Search Service for Abbreviation / Long Form